Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?

  1. Ampudia-Blasco, F.J.
  2. Romera, I.
  3. Ariño, B.
  4. Gomis, R.
Zeitschrift:
International Journal of General Medicine

ISSN: 1178-7074

Datum der Publikation: 2017

Ausgabe: 10

Seiten: 23-26

Art: Artikel

DOI: 10.2147/IJGM.S115566 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus